Trichy Mother-Child Monitoring App to Track High-Risk Pregnancies
Tiruchirappalli has launched the Trichy Mother-Child Monitoring App so health workers can track high-risk pregnant women and newborns in real time.
News
Dr Reddy’s Gets USFDA Tentative Nod for Generic Lenacapavir
Dr Reddy’s wins USFDA tentative approval under PEPFAR for generic twice-yearly lenacapavir for HIV prevention, with first supplies due before end-2026.
O-Health Raises Funding for Edge AI Clinical Models and Hardware
O-Health, a Bengaluru clinical AI startup, has raised funding backed by Apollo’s Sangita Reddy to build edge AI models and clinical hardware for hospitals.
Akums Q2 FY27 Profit Jumps 168% as CDMO Revenue Rises 39%
Akums Q2 FY27 profit rose 168% to ₹115 crore as revenue grew 31.9% to ₹1,342 crore and its CDMO business, now 83% of sales, grew 38.6%.
Wockhardt Widens Miqnaf Access as Q2 Revenue Rises 24%
Wockhardt Miqnaf access widens after DCGI lifted a supply condition on the novel antibiotic, as Q2 FY27 revenue rose 24% to ₹969 crore on biotech growth.
Alkem’s Mandva API Plant Clears USFDA Audit With Zero 483s
Alkem Laboratories’ Mandva API facility cleared a five-day USFDA inspection (26–30 October 2026) with no Form 483 observations, a cleaner result than the site’s 2023 audit.
DeepTek Cuts Price of AI TB Screening by Two-Thirds
DeepTek’s Global Access Pricing, with Unitaid and CHAI, cuts its WHO-recommended chest X-ray AI for TB screening to a third of the price in 138 countries.
OneSource Bengaluru Sterile Plant Gets USFDA VAI Status
OneSource Specialty Pharma has received a USFDA EIR with VAI classification for its Bengaluru Sterile Product Division, closing the June 2026 inspection.
Omron Starts Blood Pressure Monitor Production in Chennai
Omron Healthcare has begun full-scale blood pressure monitor production at its first India factory near Chennai, aiming for 3 million units a year by 2028.
Maharashtra Arogya Mandirs Get Village OPDs, eSanjeevani Mandate
Maharashtra makes eSanjeevani teleconsultations mandatory at Ayushman Arogya Mandirs and adds daily village OPDs and home visits under an October 29 GR.
Sun Pharma Wins CDSCO Nod for Generic Oral Semaglutide Pill
Sun Pharmaceutical Industries has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a generic […]
Assam Signs ₹600 Crore Pact for Proton Therapy Centre at GMCH
Assam has signed a ₹600 crore pact with IBA for India’s first state-run proton therapy centre at GMCH Guwahati, funded by the World Bank and the state.
Zydus Completes ₹84 Crore Buy of Sterling Biotech’s API Business
Zydus Lifesciences has closed its ₹84 crore purchase of Sterling Biotech’s API business, adding fermentation-based APIs and a plant near Vadodara.
